Fasudil fOr redUcing elopemeNt and Spatial Disorientation

计划入组 24 人 · 首次发布于 2021 年 3 月 11 日

Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation

计划入组 36 人 · 首次发布于 2025 年 3 月 24 日

Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation

计划入组 30 人 · 首次发布于 2005 年 9 月 7 日

nicotinic alpha4beta2 partial agonist (Psychogenics)

PPAR gamma partial agonist (Daiichi Sankyo)

OOR partial agonists(Tohoku Pharmaceutical University)

Spital Linth

Switzerland

Spital Zollikerberg

Switzerland

Sparian Biosciences, Inc.

United States

Air Force and Spark Biomedical Launch Trial to Combat Motion Sickness Using Neurostimulation Technology

Spatial Profiling Reveals Predictive Signatures for Pembrolizumab Response in Bladder Cancer

AI-Powered Spatial Biology Analysis Reveals New Insights into NSCLC Immunotherapy Response